Mi‐Young Son
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Molecular Biology top 5%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Gut microbiota and health
Papers in
-
- Pluripotent Stem Cells Research 37
- CRISPR and Genetic Engineering 23
- Epigenetics and DNA Methylation 15
- DNA Repair Mechanisms 11
- Cancer-related gene regulation 8
- Oncology 21
- Cancer Cells and Metastasis 10
- Cancer-related Molecular Pathways 7
- Co-authors
- Hyun‐Soo Cho (32 shared papers)Yee Sook Cho (16 shared papers)Janghwan Kim (22 shared papers)Cho‐Rok Jung (27 shared papers)Dae‐Soo Kim (27 shared papers)Mi‐Ok Lee (19 shared papers)Yong‐Mahn Han (6 shared papers)Minjeong Kim (5 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (7 papers)Experimental & Molecular Medicine (5 papers)Biomaterials (4 papers)PLoS ONE (3 papers)Nature Communications (3 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Mi‐Young Son
119 papers receiving 2.9k citations
Mi‐Young Son's Hit Papers
Peers
Comparison fields: 5 of 127
- Hepatology 201
- Molecular Biology 1.6k
- Developmental Neuroscience 74
- Oncology 431
- Cancer Research 231
Countries citing papers authored by Mi‐Young Son
This map shows the geographic impact of Mi‐Young Son's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi‐Young Son with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi‐Young Son more than expected).
Fields of papers citing papers by Mi‐Young Son
This network shows the impact of papers produced by Mi‐Young Son. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi‐Young Son. The network helps show where Mi‐Young Son may publish in the future.
Co-authors
The 25 scholars most cited alongside Mi‐Young Son, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids Hit paper breakdown → | 2019 | 278 |
| 2 | 2007 | 171 | |
| 3 | 2009 | 140 | |
| 4 | 2013 | 99 | |
| 5 | 2018 | 97 | |
| 6 | 2019 | 96 | |
| 7 | 2017 | 68 | |
| 8 | 2011 | 61 | |
| 9 | 2020 | 60 | |
| 10 | 2015 | 59 | |
| 11 | 2019 | 59 | |
| 12 | 2023 | 58 | |
| 13 | 2022 | 57 | |
| 14 | 2019 | 55 | |
| 15 | 2013 | 54 | |
| 16 | 2017 | 54 | |
| 17 | 2009 | 49 | |
| 18 | 2015 | 47 | |
| 19 | 2018 | 42 | |
| 20 | 2022 | 41 |
About Mi‐Young Son
Mi‐Young Son is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Genetics and Surgery, having authored 122 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (37 papers), CRISPR and Genetic Engineering (23 papers), 3D Printing in Biomedical Research (18 papers), Epigenetics and DNA Methylation (15 papers), DNA Repair Mechanisms (11 papers), Cancer Cells and Metastasis (10 papers), Cancer-related gene regulation (8 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Hepatology (201 citations), Molecular Biology (1.6k citations), Developmental Neuroscience (74 citations), Oncology (431 citations) and Cancer Research (231 citations). Mi‐Young Son has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Hyun‐Soo Cho, Yee Sook Cho, Janghwan Kim, Cho‐Rok Jung, Dae‐Soo Kim, Mi‐Ok Lee, Yong‐Mahn Han, Minjeong Kim, Ye Seul Son and Ohman Kwon. Their work appears in journals such as Biochemical and Biophysical Research Communications, Experimental & Molecular Medicine, Biomaterials, PLoS ONE and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.